CRBX logo

Carbiotix AB (publ) Stock Price

NGM:CRBX Community·SEK 40.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CRBX Share Price Performance

SEK 8.08
-7.04 (-46.56%)
SEK 8.08
-7.04 (-46.56%)
Price SEK 8.08

CRBX Community Narratives

There are no narratives available yet.

Recent CRBX News & Updates

Carbiotix AB (publ) Key Details

SEK 2.1m

Revenue

SEK 217.4k

Cost of Revenue

SEK 1.9m

Gross Profit

SEK 17.3m

Other Expenses

-SEK 15.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-3.09
Gross Margin
89.72%
Net Profit Margin
-728.09%
Debt/Equity Ratio
0%

Carbiotix AB (publ) Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with moderate risk.

5 Risks
0 Rewards

About CRBX

Founded
2014
Employees
8
CEO
Erik Deaner
WebsiteView website
carbiotix.com

Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test. Carbiotix AB (publ) was incorporated in 2014 and is based in Lund, Sweden.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Swedish Market Performance

  • 7 Days: 2.9%
  • 3 Months: 3.6%
  • 1 Year: -0.4%
  • Year to Date: 3.6%
The market is up 2.9% in the last 7 days, led by the Industrials and all sectors gaining ground. The market has been flat overall in the last year. Earnings are forecast to grow by 16% annually. Market details ›